SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Immune Network Research ( IMM-V ) -- Ignore unavailable to you. Want to Upgrade?

To: John who wrote (44)5/15/1998 8:05:00 PM
From: John Fairchild  Read Replies (1) | Respond to of 57
 
I saw the original NR back when the 2nd clinical testing it was announced on April 14. No market response so I moved on. When you dig a little deeper you begin to see just how undervalued this stock might be. With only 20 mil shares out they have a very small market cap compared to similar companies in HIV research. Take a look at NVO or IMT huge market caps by comparison. I took a position today. Hope it is not going to be another pump and dump by scum sucking brokerage houses. One thing that is positive however is that this one is moving without media attention or internet attention so far.

John



To: John who wrote (44)5/16/1998 3:24:00 PM
From: Harold W. Davis  Read Replies (1) | Respond to of 57
 

A friend has been a shareholder for about a year now. He has been optimistic about the company's prospects for some time.

The market has been sleepy in recent months but with the new developments I've personally taken a keen interest in the story and I am now a shareholder. The potential is huge in my opinion and the market is beginning to recognize what's going on!!!



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News